These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases. Krenke K; Peradzyńska J; Lange J; Banaszkiewicz A; Łazowska-Przeorek I; Grzela K; Radzikowski A; Kulus M Pediatr Pulmonol; 2014 Dec; 49(12):1190-5. PubMed ID: 24339443 [TBL] [Abstract][Full Text] [Related]
11. [The interleukin-6 level in exhaled breath condensate of patients with obstructive sleep apnea-hypopnea syndrome]. Qiao H; Wang GF; Zhang H; Ding CM Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jun; 28(6):364-7. PubMed ID: 16008970 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal roles of STAT3 and STAT5 in nasal polyposis. Wang XQ; Hu GH; Kou W; Shen Y; Kang HY; Hong SL Am J Otolaryngol; 2012; 33(6):741-52. PubMed ID: 22959364 [TBL] [Abstract][Full Text] [Related]
13. pH in exhaled breath condensate and nasal lavage as a biomarker of air pollution-related inflammation in street traffic-controllers and office-workers. Lima TM; Kazama CM; Koczulla AR; Hiemstra PS; Macchione M; Fernandes AL; Santos Ude P; Bueno-Garcia ML; Zanetta DM; André CD; Saldiva PH; Nakagawa NK Clinics (Sao Paulo); 2013 Dec; 68(12):1488-94. PubMed ID: 24473505 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394 [TBL] [Abstract][Full Text] [Related]
16. [Expression and role of IL-17 in nasal polyposis]. Shen Y; Hong S; Hu G Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Apr; 28(8):516-9. PubMed ID: 25007662 [TBL] [Abstract][Full Text] [Related]
17. Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Rosias PP; Dompeling E; Dentener MA; Pennings HJ; Hendriks HJ; Van Iersel MP; Jöbsis Q Pediatr Pulmonol; 2004 Aug; 38(2):107-14. PubMed ID: 15211692 [TBL] [Abstract][Full Text] [Related]
18. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP). Veyseller B; Aksoy E; Ertaş B; Keskin M; Ozturan O; Yildirim YS; Bayraktar EG; Oztürk H B-ENT; 2010; 6(2):105-9. PubMed ID: 20681362 [TBL] [Abstract][Full Text] [Related]
19. Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma. Carpagnano GE; Foschino Barbaro MP; Resta O; Gramiccioni E; Valerio NV; Bracciale P; Valerio G Eur J Pharmacol; 2005 Sep; 519(1-2):175-81. PubMed ID: 16122732 [TBL] [Abstract][Full Text] [Related]
20. Bronchial interleukin-5 and eotaxin expression in nasal polyposis. Relationship with (a)symptomatic bronchial hyperresponsiveness. Lamblin C; Bolard F; Gosset P; Tsicopoulos A; Perez T; Darras J; Janin A; Tonnel AB; Hamid Q; Wallaert B Am J Respir Crit Care Med; 2001 Apr; 163(5):1226-32. PubMed ID: 11316663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]